Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Redburn Partners Initiates Coverage On Visa with Sell Rating

Redburn Partners Initiates Coverage On Visa with Sell Rating

Redburn Partners analyst Fahed Kunwar initiates coverage on Visa (NYSE:V) with a Sell rating.

byBenzinga Newsdesk

November 29, 2022

1 minute read

Redburn Partners analyst Fahed Kunwar initiates coverage on Visa (NYSE:V) with a Sell rating.

Analyst Ratings

Analyst Ratings for Western Midstream

By Benzinga Insights

April 18, 10:01 AM

Analysts have provided the following ratings for Western Midstream (NYSE:WES) within the last quarter: Bullish Somewhat Bullish Indifferent…

WES

Cathie Wood Favorite Ginkgo Bioworks Bolsters Biosecurity Platform Via This Acquisition

By Akanksha Bakshi

August 19, 12:34 PM

Ginkgo Bioworks Holdings Inc (NYSE:DNA) has purchased certain epidemiological data infrastructure assets from Baktus, Inc., a Delaware-based public benefit corporation.…

DNA

Why Are Timber Pharmaceuticals Shares Trading Higher Today

By Vandana Singh

June 5, 8:31 AM

The FDA has granted dermal carcinogenicity (CARC) waiver for Timber Pharmaceuticals Inc's (NYSE: TMBR) TMB-001, a topical isotretinoin formulated using the company's patented IPEG delivery system.

TMBR

Top Apple Exec Points To Steve Jobs Era For Lack Of Meeting Records, Casts Doubt On App Store’s Profitability

By Rounak Jain

April 17, 9:39 AM

Schiller's uncertainty can be chalked back to Apple co-founder Steve Jobs, who prevented minutes of meetings from being recorded.

AAPL

Redburn Partners Initiates Coverage On Visa with Sell Rating

Related Posts

Analyst Ratings for Western Midstream

Cathie Wood Favorite Ginkgo Bioworks Bolsters Biosecurity Platform Via This Acquisition

Why Are Timber Pharmaceuticals Shares Trading Higher Today

Top Apple Exec Points To Steve Jobs Era For Lack Of Meeting Records, Casts Doubt On App Store’s Profitability